Sfoglia per Rivista ONCOTARGET
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia.
2012-01-01 Chiarini, F; Lonetti, A; Teti, G; Orsini, E; Bressanin, D; Cappellini, Alessandra; Ricci, F; Tazzari, Pl; Ognibene, A; Falconi, M; Pagliaro, P; Iacobucci, I; Martinelli, G; Amadori, S; Mccubrey, Ja; Martelli, A. M.
Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for Hepatocellular carcinoma: correlation with histologic grade
2016-01-01 Granata, Vincenza; Fusco, Roberta; Catalano, Orlando; Guarino, Benedetta; Granata, Francesco; Tatangelo, Fabiana; Avallone, Antonio; Piccirillo, Mauro; Palaia, Raffaele; Izzo, Francesco; Petrillo, Antonella
PI3K paninhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors
2015-01-01 Annalisa, Lonetti; Cappellini, Alessandra; Antonino Maria, Spartà; Francesca, Chiarini; Francesca, Buontempo1; Camilla, Evangelisti; Cecilia, Evangelisti; Ester, Orsini; James A., Mccubrey; Alberto Maria, Martelli
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the proapoptotic NF-κB
2016-01-01 Buontempo, F; Orsini, E; Lonetti, A; Cappellini, Alessandra; Chiarini, F; Evangelisti, C; Evangelisti, C; Melchionda, F; Pession, A; Bertaina, A; Locatelli, F; Bertacchini, J; Neri, Lm; Mccubrey, Ja; Martelli, A. m. 1.
Two hits are better than one: targeting both phosphatidylinositol3-kinase and mammalian target of rapamycin as a therapeuticstrategy for acute leukemia treatment
2012-01-01 Martelli, A. M.; Chiarini, F.; Evangelisti, C.; Cappellini, Alessandra; Buontempo, F.; Bressanin, D.; Fini, M.; Mccubrey, J. A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. | 1-gen-2012 | Chiarini, F; Lonetti, A; Teti, G; Orsini, E; Bressanin, D; Cappellini, Alessandra; Ricci, F; Tazzari, Pl; Ognibene, A; Falconi, M; Pagliaro, P; Iacobucci, I; Martinelli, G; Amadori, S; Mccubrey, Ja; Martelli, A. M. | |
| Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for Hepatocellular carcinoma: correlation with histologic grade | 1-gen-2016 | Granata, Vincenza; Fusco, Roberta; Catalano, Orlando; Guarino, Benedetta; Granata, Francesco; Tatangelo, Fabiana; Avallone, Antonio; Piccirillo, Mauro; Palaia, Raffaele; Izzo, Francesco; Petrillo, Antonella | |
| PI3K paninhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors | 1-gen-2015 | Annalisa, Lonetti; Cappellini, Alessandra; Antonino Maria, Spartà; Francesca, Chiarini; Francesca, Buontempo1; Camilla, Evangelisti; Cecilia, Evangelisti; Ester, Orsini; James A., Mccubrey; Alberto Maria, Martelli | |
| Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the proapoptotic NF-κB | 1-gen-2016 | Buontempo, F; Orsini, E; Lonetti, A; Cappellini, Alessandra; Chiarini, F; Evangelisti, C; Evangelisti, C; Melchionda, F; Pession, A; Bertaina, A; Locatelli, F; Bertacchini, J; Neri, Lm; Mccubrey, Ja; Martelli, A. m. 1. | |
| Two hits are better than one: targeting both phosphatidylinositol3-kinase and mammalian target of rapamycin as a therapeuticstrategy for acute leukemia treatment | 1-gen-2012 | Martelli, A. M.; Chiarini, F.; Evangelisti, C.; Cappellini, Alessandra; Buontempo, F.; Bressanin, D.; Fini, M.; Mccubrey, J. A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile